School Based Malaria Control in Ugandan Schoolchildren

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that schoolchildren treated with IPT using DP over one year of follow-up will have a different risk of clinical malaria compared to those treated with placebo.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Makerere University
• Collaborator: Bill and Melinda Gates Foundation
• Treatments: Artenimol; Dihydroartemisinin; Piperaquine

Criteria

Inclusion Criteria:

• Age ≥ 6 - 14 years

• Pupils enrolled at participating school

• Willingness of the parent/guardian to provide consent

• Provision of assent by pupil (those above 8 years)

Exclusion Criteria:

• Known allergy or history of adverse reaction to study medications

• Intention of changing of schools during the follow-up period

• History (obtained from the parent/guardian) of any known serious chronic disease requiring frequent medical care